While we found a nominally lower level of FOXP3 protein expression in AMPK-deficient compared with AMPK-sufficient Treg cells at baseline, this difference was not evident in the tumor and infected lung microenvironments, indicating that the mechanisms controlling FOXP3 level in these settings are not dependent on AMPK. This evidence concerns the gene PRKAA2 and neoplasm.